Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells

BACKGROUND: Around 20%–30% of breast cancers overexpress the proto-oncogene human epidermal growth receptor 2 (HER2), and they are characterized by being very invasive. Therefore, many current studies are focused on testing new therapies against tumors that overexpress this receptor. In particular,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Nanomedicine
Autori principali: Rodríguez-Serrano, Fernando, Mut-Salud, Nuria, Cruz-Bustos, Teresa, Gomez-Samblas, Mercedes, Carrasco, Esther, Garrido, Jose Manuel, López-Jaramillo, F Javier, Santoyo-Gonzalez, Francisco, Osuna, Antonio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2016
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034911/
https://ncbi.nlm.nih.gov/pubmed/27698563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S112560
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi